PRF Technologies Ltd. is a specialty pharmaceutical company focused on reformulating established therapeutics for clinical use. Its current portfolio centers on post-surgical pain management and localized drug-delivery solutions, including PRF-110, an oil-based formulation designed for direct application into the surgical wound bed to provide sustained analgesia, and OcuRing-K, a bio-erodible implant developed for use in cataract surgery. The company operates in the healthcare sector with an emphasis on developing proprietary treatment options that target specific surgical settings and recovery needs. Headquartered in Tel Aviv, Israel, PRF Technologies also maintains activity in advanced drug-delivery technologies, supporting its role as a niche player in specialty therapeutics and perioperative care.
Website65 Yigal Alon St.
Tel Aviv, 6744316
Israel
Investors talking about PRFX also mention
What share of all stock conversation is about PRFX?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% +0 | 0% 0 | 0% +0 | 0% 0 |
Of the messages about PRFX that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | 100% 0 | 100% 0 | 96.97% +3.22 | 81.28% +8.91 | ||
| Bearish | 0% 0 | 0% 0 | 3.03% -3.22 | 18.72% -8.91 |
Of the messages about PRFX that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | — | 100% | 100% | 26.51% | ||
| Earnings | — | 0% | 0% | 0.34% | ||
| Macro | — | 0% | 0% | 14.93% | ||
| Analysts | — | 0% | 0% | 14.09% | ||
| Controversies | — | 0% | 0% | 0% | ||
| Technical Analysis | — | 0% | 0% | 44.13% |
Of the messages about PRFX, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 100% | 85.29% | 81.37% | 45.91% | ||
| Newcomers | 0% | 14.71% | 18.63% | 54.09% |